Literature DB >> 27225789

The Canadian guidelines for the withdrawal of life-sustaining treatment: the role of evidence.

Mohamed Y Rady1, Joseph L Verheijde2.   

Abstract

Mesh：

Year:  2016        PMID： 27225789     DOI： 10.1007/s00134-016-4372-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  6 in total

1.  The Standardization Approach in End-of-Life Withdrawal of Life-Sustaining Treatment: Sacrificing Patient's Safety and the Quality of Care.

Authors:  Mohamed Y Rady; Joseph L Verheijde
Journal:  J Intensive Care Med       Date:  2015-04-02       Impact factor: 3.510

2.  Guidelines for the withdrawal of life-sustaining measures.

Authors:  James Downar; Jesse W Delaney; Laura Hawryluck; Lisa Kenny
Journal:  Intensive Care Med       Date:  2016-04-08       Impact factor: 17.440

3.  Variable Patterns of Continuous Morphine Infusions at End of Life.

Authors:  Katrina J Lin; Andrea Ching; Kyle P Edmonds; Eric J Roeland; Carolyn Revta; Joseph D Ma; Rabia S Atayee
Journal:  J Palliat Med       Date:  2015-06-24       Impact factor: 2.947

4.  Narcotic and benzodiazepine use after withdrawal of life support: association with time to death?

Authors:  Jeannie D Chan; Patsy D Treece; Ruth A Engelberg; Lauren Crowley; Gordon D Rubenfeld; Kenneth P Steinberg; J Randall Curtis
Journal:  Chest       Date:  2004-07       Impact factor: 9.410

Review 5.  Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness.

Authors:  Hayley Barnes; Julie McDonald; Natasha Smallwood; Renée Manser
Journal:  Cochrane Database Syst Rev       Date:  2016-03-31

6.  Pharmacokinetics of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Terminally Ill Adult Patients.

Authors:  Linda G Franken; Anniek D Masman; Brenda C M de Winter; Birgit C P Koch; Frans P M Baar; Dick Tibboel; Teun van Gelder; Ron A A Mathot
Journal:  Clin Pharmacokinet       Date:  2016-06       Impact factor: 6.447
  6 in total
  1 in total

1.  Neither guidelines nor symptom-targeted opioids are harmful when withdrawing life-sustaining measures.

Authors:  James Downar; Jesse Delaney; Laura Hawryluck; Lisa Kenny
Journal:  Intensive Care Med       Date:  2016-05-25       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.